AQUESTIVE THERAPEUTICS INC (AQST) — insider trading
Health Care · NASDAQ
AQUESTIVE THERAPEUTICS INC (AQST) has 15 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 15 (latest 2026-06-23).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-23 | Krop Julie | Director | Option exercise / conversion (derivative) | 25,000 | $0.00 | $0 | Form 4 |
| 2026-06-23 | Krop Julie | Director | Open-market sale | 25,000 | $5.02 | $125.4K | Form 4 |
| 2026-06-23 | Krop Julie | Director | Option exercise / conversion | 25,000 | $0.71 | $17.8K | Form 4 |
| 2026-06-15 | Barber Daniel | Officer (President and CEO) | Open-market sale | 25,000 | $4.16 | $104.0K | Form 4 |
| 2026-06-10 | Taglietti Marco | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | BROWN GREGORY B | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Cochran John | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Jenkins Abigail L. | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | Krop Julie | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-10 | MORRIS TIMOTHY E | Director | Grant / award / vesting (derivative) | 50,500 | $0.00 | $0 | Form 4 |
| 2026-06-08 | Korczynski Sherry | Officer (Chief Commercial Officer) | Shares withheld for taxes / exercise cost | 2,714 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Zalewski Thomas A. | Officer (Chief Legal Officer) | Grant / award / vesting (derivative) | 75,000 | $0.00 | $0 | Form 4 |
| 2026-05-18 | Zalewski Thomas A. | Officer (Chief Legal Officer) | Grant / award / vesting | 100,000 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Cioffi Melina | Officer (SVP, Regulatory Affairs) | Shares withheld for taxes / exercise cost | 1,667 | $4.17 | $7.0K | Form 4 |
| 2026-05-15 | Barber Daniel | Officer (President and CEO) | Open-market sale | 8,257 | $4.29 | $35.4K | Form 4 |
Ask the chat about AQST's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AQUESTIVE THERAPEUTICS INC (AQST).
Last updated 2026-06-23 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.